SXTC — China SXT Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- $12.67m
- -$0.81m
- $2.60m
Annual cashflow statement for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.19 | 1.54 | -10.3 | -2.75 | -5.74 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | 0.067 | 9.05 | 2.89 | 2.89 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.609 | -1.54 | 1.95 | -1.61 | 2.46 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.92 | 0.239 | 0.934 | -1.32 | 0.268 |
| Capital Expenditures | -1.05 | -0.61 | -0.407 | -0.093 | -0.062 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.092 | — | -5.09 | -5.71 | 0.016 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.14 | -0.61 | -5.5 | -5.81 | -0.047 |
| Financing Cash Flow Items | — | 2.52 | -3.7 | 12.5 | -3.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.314 | 9.04 | 3.02 | 12.4 | 1.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.495 | 8.63 | -2 | 6.07 | 2.21 |